Diseases mimicking a burn - outcome and treatment
- PMID: 21990994
- PMCID: PMC3187986
Diseases mimicking a burn - outcome and treatment
Abstract
Burn care is not reserved uniquely to burns. Several diseases have the symptomatology, clinical presentation, complications, treatment requirements, and outcome of burns. Such diseases are: 1. Stevens-Johnson disease; 2. Lyell's syndrome; 3. bacterial fasciitis; 4. skin necrosis combined with coagulation disturbances; 5. pemphigoid; and 6. subacute cutaneous lupus erythematosus.
Les soins des brûlures ne sont pas limités uniquement aux brûlures. Il y a plusieurs maladies qui possèdent la symptomatologie, la présentation clinique, les complications, les exigences de traitement et les résultats des brûlures. Ces maladies sont les suivantes : 1. maladie de Stevens-Johnson ; 2. syndrome de Lyell ; 3. fasciite bactérienne ; 4. nécrose cutanée unie à des troubles de la coagulation ; 5. pemphigoïde ; 6. lupus érythémaeux cutané subaigu.
Keywords: burn; diseases; mimicking; treatment.
Figures
Similar articles
-
Effectiveness of Suprathel® application in partial thickness burns, frostbites and Lyell syndrome treatment.Pol Przegl Chir. 2011 Oct;83(10):541-8. doi: 10.2478/v10035-011-0086-5. Pol Przegl Chir. 2011. PMID: 22189281
-
Skin reactions to co-trimoxazole.Infection. 1987;15 Suppl 5:S254-8. doi: 10.1007/BF01643199. Infection. 1987. PMID: 2963792
-
Lyell's syndrome on a burns unit.Burns. 1994 Aug;20(4):368-70. doi: 10.1016/0305-4179(94)90072-8. Burns. 1994. PMID: 7945833
-
Burn Center Care of Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.Clin Plast Surg. 2017 Jul;44(3):583-595. doi: 10.1016/j.cps.2017.02.016. Clin Plast Surg. 2017. PMID: 28576247 Review.
-
Management of ocular conditions in the burn unit: thermal and chemical burns and Stevens-Johnson syndrome/toxic epidermal necrolysis.J Burn Care Res. 2011 Sep-Oct;32(5):547-60. doi: 10.1097/BCR.0b013e31822b0f29. J Burn Care Res. 2011. PMID: 21799437 Review.
Cited by
-
Severe idiosyncratic drug reactions with epidermal necrolysis: A 5-year study.Indian J Plast Surg. 2011 Sep;44(3):467-73. doi: 10.4103/0970-0358.90824. Indian J Plast Surg. 2011. PMID: 22279281 Free PMC article.
-
Toxic Epidermal Necrolysis Syndrome: Management And Outcomes.Ann Burns Fire Disasters. 2021 Sep 30;34(3):226-234. Ann Burns Fire Disasters. 2021. PMID: 34744537 Free PMC article.
References
-
- Trent J.T., Kirsner R.S., Romanelli P., Kerdel F.A. Use of SCORTEN to accurately predict mortality in patients with toxic epidermal necrolysis in the United States. Arch. Dermatol. 2004;140:890–2. - PubMed
-
- Cornish P., Mittmann N., Gomez M., Cartotto R.C., Fish J.S. Cost of medications in patients admitted to a burn center. Am. J. Clin. Dermatol. 2003;4:861–7. - PubMed
-
- Stevens-Johnson syndrome and toxic epidermal necrolysis:Oncologic considerations. Clin. J. Oncol. Nurs. 2004;8:27–30. 55–55. - PubMed
-
- Stevens-Johnson syndrome after immunization with smallpox, anthrax, and tetanus vaccines. Mayo Clin. Proc. 2004;79:1193–6. - PubMed
-
- Mockenhaupt M., Kelly J.P., Kaufman D., Stern R.S., SCAR Study Group. The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with nonsteroidal anti-inflammatory drugs: A multinational perspective. J. Rheumatol. 2003;30:2234–40. - PubMed
LinkOut - more resources
Full Text Sources